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ABSTRACT: Vesosomes are nested liposomal structures with high potential as advanced drug delivery vehicles, bioreactors and 
artificial cells. However, to date no method has been reported to prepare monodisperse vesosomes of controlled size. Here we 
report on a multi-step microfluidic strategy for hierarchically assembling uniform vesosomes from dewetting of double emulsion 
templates. The exquisite control afforded by our method is illustrated by the formation of concentric, pericentric and multicom-
partment liposomes. The microfluidic route to vesosomes offers an exceptional platform to build artificial cells as exemplified by 
the in vitro transcription in “nucleus” liposomes and the mimicry of architecture of eukaryotic cells. Finally, we showed the 
transport of small molecules across the nucleic envelope via insertion of nanopores into the bilayers.  
Vesosomes are multicompartmental liposomal structures of varied architectures.
1
 These multivesicular vesicles can consist of 
multilayered concentric liposomes, or multiple liposomes arranged within or around large liposomes. These structures, as well 
as related multicompartment polymersomes
2
 and proteinosomes,
3
 have generated significant interest for their potential as drug 
delivery vehicles
1a,4
, compartmentalized nano- or microscale bioreactors,
5
 or as artificial cell/protocell models.
6
 Zasadzinski and 
coworkers have shown that vesosomes can protect encapsulated drug carrying compartments from blood components due to 
the presence of double bilayers,
4d
 and slow vesicle contents release.
4e
 Bolinger et al.
5b,c
 employed multicompartment vesosomes 
to perform consecutive enzymatic reactions by thermally remote release of different compounds encapsulated in smaller lipo-
somes. Remarkably, vesosomes that contain a “nucleus” or “organelles” represent a promising new concept towards the design of 
artificial cells, especially the artificial eukaryotic cells.
6a
 However, conventional methods,
7
 such as bulk hydration
8
 or electrofor-
mation
9
 of dried lipid membranes, do not readily yield complex hierarchical vesicular structures, and certainly do not provide 
any control over dimensions, offer low encapsulation efficiencies and low yields. Moreover, these strategies do not allow a sys-
tematic simultaneous loading of different components into diverse compartments. These limitations have severely hindered 
progress in the application of such multivesicular liposomes. Recently, droplet microfluidics has been shown to offer excellent 
emulsion templates for the preparation of monodisperse liposomes
10
 as well as polymersomes
2a,c,11
, but no vesosomes have been 
reported. 
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Figure 1. (a) Schematic illustration and (b) snapshots of the microfluidic preparation of double emulsions with an inner lipo-
some and the assembly of vesosomes from emulsion dewetting. (c,d) Confocal images of the monodisperse vesosomes with one 
(c), two (d), three and four (insets in d) inner liposomes. (e) The size distribution of inner and outer liposomes of the vesosomes 
in c. (f) As-formed vesosomes with different-sized interior liposomes. Scale bars, 100 µm. 
Recently, we have presented a surfactant-assisted microfluidic strategy for assembling monodisperse liposomes from water-in-
oil-in-water (W/O/W) double emulsion droplets.
10a
 In this paper, we demonstrate the hierarchical assembly of uniform veso-
somes via multi-dewetting processes. Briefly, the single liposomes formed from dewetting of microfluidically prepared W/O/W 
emulsion droplets were reinjected into the microfluidic devices as the inner phase to fabricate larger W/O/W emulsion droplets 
loaded with smaller liposomes. The high-order templates will undergo a second dewetting transition to form uniform liposome-
in-liposome vesicles. The exquisite control afforded by our method is illustrated by the formation of concentric, pericentric and 
multicompartment liposomes. The resultant vesosomes are potentially used as complex artificial cell models. To this end, co-
encapsulation of in vitro transcription (IVTx) mix into the “nucleus” liposomes and an in vitro transcription/translation (IVTT) 
mix into the exterior liposomes was demonstrated. We were able to follow IVTx in real time using RNA aptamers. Finally, we 
showed the transfer of molecules between vesosome compartments through insertion of membrane proteins into the nucleus 
bilayers to create nanopores. The microfluidic route to uniform vesosomes of controlled size can facilitate research as diverse as 
advanced drug delivery systems, artificial cells and microreactors. 
To produce monodisperse vesosomes, we first fabricated monodisperse single liposomes as the “nuclei” according to our re-
cent publication.
10a
 Briefly, we used a glass capillary microfluidic device which comprised of two tapered cylindrical capillaries 
inserted into opposite ends of a square capillary to prepare W/O/W double emulsion droplets (Figure S1) which were utilized to 
form liposomes (Figure S2) by a dewetting transition. Subsequently, the preformed single liposomes dispersed in an aqueous 
phase (W1, see SI Materials for details) were reinjected into the microfluidic device as the new inner phase to make larger 
W/O/W double emulsion droplets (Figures 1a, b1, S2 and Movie S1, see SI Materials for details of the middle oil phase (O) and 
the outer water phase (W2). In this way, smaller liposomes were successfully loaded within double emulsion droplets. Along 
with the evaporation of the chloroform fraction of the oil phase, the oil shells of the larger double emulsion droplets gradually 
dewetted from the interior drops (Figure 1b2), forming vesosomes and separated oil drops with excess lipids (Figure 1b3). To 
visualize the vesosomes clearly, fluorescein isothiocyanate-dextran (FITC-Dextran) and rhodamine B isothiocyanate-Dextran 
(RITC-dextran) were respectively used to label the inner and outer liposomes in some experiments (Figures 1c,d,f). This micro-
fluidic method gives control over the vesosome dimensions and configurations. As Figure 1c shows, the resultant vesosomes are 
uniform; their internal and external mean diameters are 43 µm and 102 µm respectively and their coefficients of variation are 5% 
and 3% respectively (Figure 1e). Remarkably, the number of the interior liposomes can be varied by tuning the flow rates. For 
example, we fixed the flow rates of middle and outer phases at 500 and 4000 µL h
-1
 respectively, and adjusted the inner phase 
flow rates from 200, 280, 350 to 400 µL h
-1
 to prepare vesosomes containing two, three and four inner liposomes (Figures 1c,d). In 
addition, vesosomes with diverse dimensions of sub-compartments were also fabricated. As Figures 1f and S3 show, the shell 
volumes between interior and exterior liposomes can be easily adjusted, which allow the precise load of ingredients. 
Further, the droplet microfluidic technique has shown considerable flexibility in encapsulation of distinct droplets in multiple 
emulsion droplets,
12
 which offers perfect templates to create structured vesosomes. To demonstrate this idea, we upgraded the 
microfluidic device with two independent inlets (Figure 2a),
10a
 which were employed to inject two kinds of liposomes to prepare 
double emulsion droplets with different inner liposomes. Similarly, these emulsion templates underwent a complete dewetting 
to generate vesosomes containing distinct liposomes. As Figure 2b shows, vesosomes with diverse inner structures (labeled by 
FITC-Dextran and Alexa Fluor® 647 respectively) were successfully achieved. We note that the pairing of reinjected liposomes is 
the key point to generate vesosomes with controlled numbers and types of inner liposomes. The method can be extended to 
  
3 
make more complex concentric multicompartment vesosomes, for example, liposome-in-liposome-in-liposome vesosomes (Fig-
ures 2 c and d). 
The vesosomes essentially represent liposomes which contain a “nucleus” or “organelles”, and represent a promising new con-
cept towards the design of artificial cells, especially the artificial eukaryotic cells. Although liposomes have been widely em-
ployed as protocells or artificial cells to imitate the architectures and functions of prokaryotic cells, such as cell division,
13
 RNA 
replication
14
 and IVTT,
6d
 the mimicry of intracellular compartmentalization both in structures and functions remains underex-
plored, mostly because the highly ordered vesicles required, are difficult to make. Furthermore, conventional routes to the veso-
somes typically do not efficiently co-encapsulate different solutions into different sub-compartments. Here, we show the ad-
vantages of our microfluidic approach in loading diverse complex components and the potential of the resultant vesosomes in 
building artificial cells. 
 
Figure 2. (a) Schematic illustration of the microfluidic preparation of double emulsions with distinct interior liposomes and the 
dewetting process. (b) Confocal images of the vesosomes with different numbers and ratios of interior liposomes. (c,d) Schemat-
ic and confocal images show the formation of triple vesosomes and the resultant structures. Scale bars, 100 µm. 
To mimic the key function of cell nuclei, we encapsulated an IVTx mix in single liposomes to synthesize RNA (Figure 3a). This 
mix contains T7 RNAP, pyrophosphatase, DNA template, RNase inhibitor and feeding buffer (see SI IVTx in nucleus liposomes & 
IVTT for details), and all components were successfully loaded in inner droplets during the double emulsion template prepara-
tion. To visualize the RNA generation, we coded the plasmids with a sequence for Spinach2 aptamer (an RNA mimic of GFP) 
that can bind a dye called 5-difluoro-4-hydroxybenzylidene imidazolinone (DFHBI) to form a fluorescent complex of Spinach2-
DFHBI (Figure 3b); both DFHBI and Spinach2 are non-fluorescent until binding occurs.
15
 As Figures 3c, d, S4 and Movie S2 show, 
the fluorescence intensity of Spinach2-DFHBI in liposomes notably increased from 0 min to 60 min and up to 120 min during the 
IVTx. After 2 h expression, the fluorescence signal reached a plateau probably due to running out of nutrients (Figure 3d). This 
agrees well with the IVTx reaction in bulk recorded by a plate reader (Figure S5).  
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Figure 3. (a,b) Cartoons show in situ detection of IVTx inside the liposomes (a) and the work principle of the RNA aptamer 
Spinach2. (c) Sequence images of generation of RNA in the liposomes. (d) The RNA expression kinetics. (e) Independent encap-
sulation of IVTx mix (Spinach2-DFHBI) into interior liposomes and IVTT mix (mRFP) into exterior liposomes. (f) IVTx in nucle-
us liposome of vesosomes.  Scale bars, 50 µm. 
 
Figure 4. Insertion of membrane pore peptide melittin into the interior bilayers. (a) Cartoons and (b) confocal image series 
show protein pore-mediated transport of fluorescent molecules from inner liposomes to outer liposomes. (c,d) Control experi-
ment: no melittin was added. (e) Kinetics of time-dependent release of calcein from inner liposome to outer liposome. Curves 1, 
2, 3 and 4 mean the fluorescence intensity over time in relevant liposomes as shown in a and c. Scale bars, 50 µm. 
To mimic the architecture of eukaryotic cells, we embedded the single liposomes that contain IVTx mix as artificial nuclei into 
larger liposomes. In the larger droplets, IVTT mix (consisting of one-third Escherichia coli cell lysate and two-thirds feeding 
buffer, see SI IVTx in nucleus liposomes & IVTT for details)
16
 for monomeric red fluorescent protein (mRFP) was encapsulated to 
form a kind of “cytoplasm” phase (Figure 3e). RNA was successfully expressed inside the nucleus liposomes as shown in Figures 
3e (last image) and 3f. Moreover, most of the as-formed artificial cell models are stable for more than 8 h, which is sufficient for 
IVTT or related research. Recently we already demonstrated the in vitro expression of enhanced green fluorescent protein 
(eGFP) in liposomes.
10a
 As we here show that transcription and translation can in principle be carried out in two different com-
partments of the artificial cells, the final key (and probably most challenging) step would be to realize the transfer of RNA across 
lipid bilayers. 
The controlled passage of nutrient molecules and wastes is a key feature of biological cells, in which the nanopores play an 
important role in both cell envelops and nucleic shells. Therefore, to demonstrate the feasibility of molecule transfer between 
sub-compartments in vesosomes, we inserted a membrane protein melittin into the nucleus liposomes to create nanopores. 
Melittin self-assembles into bilayers to create pores of 1-3 nm or 3.5-4.5 nm in diameter depending on the number of assembly 
subunits,
17
 which allows small molecules to transfer. As Figure 4a shows, we loaded the inner liposomes with melittin monomers 
(2 μM) and calcein fluorescent molecules (Mw= 623 g mol
-1
, 10 μM) and outer liposomes with RITC-Dextran (average Mw= 
70,000 g mol
-1
), and then observed the fluorescence intensity over time. Once the nanopores were formed in the nucleus bi-
layers, the green dye (calcein) in the inner liposomes rapidly (about 2 min) diffused into the outer liposomes, while the red dye 
(RITC-Dextran) in the outer liposome failed to diffuse into the inside because of the larger molecule weight (Figure 4b, Movie 
S3). This size exclusion phenomenon also indicates that the morphologies of both the inner and outer liposomes are intact, en-
suring that the release of the fluorescent molecules is not because of the burst of inner liposomes. After the dye diffusion, the 
distribution of calcein in the vesosomes is homogeneous (second row in Figure 4b and Figure 4e). In contrast, in the absence of 
membrane proteins, both compartments of the vesosomes only exhibit a slight decay in fluorescence even after 2 h (Figures 4c-e, 
Movie S3), may due to photobleaching; no dye transfer was observed. Furthermore, it has been reported that insertion of other 
membrane proteins into the liposomal bilayers forms nanopores of different sizes, for example, alpha-hemolysin (αHL) creates 
pores of 1.4 nm in diameter.
18
 Therefore, it is feasible to selectively insert different membrane proteins, for example, melittin and 
αHL, into internal and external liposomes respectively to create different nanopores, which will endow different vesosome com-
partments with different permeability properties. This will open up platforms to study the communications between artificial 
cell compartments and that between compartment and surrounding environment.  
In summary, we have reported a multi-step microfluidic strategy for the hierarchical assembly of uniform vesosomes from 
dewetting of W/O/W double emulsion droplets. To show the exceptional control over vesosome formation in our method, con-
centric, pericentric and multicompartment liposomes with distinct contents were successfully created. These structures offer an 
advanced platform to build artificial cell models as exemplified by the encapsulation of solutions as complex as that for IVTx and 
IVTT into the different compartments, and real time detection of RNA generation in liposomes. Finally, we showed the insertion 
of nanopores into the bilayers of the nucleus liposomes, which allows for the transport of small molecules across the nucleic 
envelopes. Future work will focus on nanopore-mediated transfer of RNA across bilayers and coupled IVTT in vesosome systems. 
We believe that this approach for fabricating uniform vesosomes with well-defined sizes, will facilitate artificial cell related re-
search like enzyme storage and release, membrane fusion, vesicle transport and multi-step bioprocesses.   
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Supplementary experimental section, figures and movies are available free of charge on the ACS Publications website at DOI:   
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